Dr. Martijn Meijerink
Interventional Radiologist
1 Podcast on BackTable
Dr. Martijn Meijerink is an interventional radiologist and primary investigator of the COLLISION Trial at UMC Amsterdam.
Learn from the experiences and expertise of Dr. Martijn Meijerink and other leading voices in your specialty on the BackTable app.
Episode # 543 • 13 May 2025
Metastatic Colorectal Cancer: Discussion on the COLLISION Trial
Is minimally invasive ablation the future of metastatic cancer care? We now have the results of the COLLISION Trial, which investigates the non-inferiority of thermal ablation compared to surgical resection. How will these findings change treatment paradigms and practice patterns around metastatic colorectal cancer? In this week’s episode of BackTable, interventional radiologist Dr. Chris Beck discusses the impact and implications of the COLLISION Trial with principal investigator Dr. Martijn Meijerink from Amsterdam UMC.
More from Dr. Martijn Meijerink
About
Dr. Martijn Meijerink studied medicine at Catholic University of Leuven (Belgium) and has been affiliated with Amsterdam UMC since 2003, initially completing radiology training before joining the institution as a staff radiologist. His primary area of expertise is interventional radiology, with a particular focus on oncological interventional radiology and image-guided cancer treatments. In 2010, Dr. Martijn Meijerink earned his PhD with research titled "Novel Dynamic Imaging Techniques and Ablative Therapies for Metastatic Liver Disease." Since 2011, he has served as a training supervisor for the interventional radiology differentiation and fellowship program, helping to educate and mentor the next generation of interventional radiologists.
In addition to his clinical and educational responsibilities, Dr. Martijn Meijerink supervises multiple PhD candidates and serves as the principal investigator on several scientific research projects focused on minimally invasive, image-guided cancer treatments. His work is dedicated to advancing innovative interventional oncology techniques that improve outcomes and expand treatment options for patients with cancer.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.